College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
 
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
 
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > CAP Media Center > CAP News Release Index > Phoenix Pathologist Selected for College of American Pathologists Foundation 2008-09 Scholars Program
Printable Version

  Press Release

 

Published on March 20, 2008

Phoenix Pathologist Selected for College of American Pathologists Foundation 2008-09 Scholars Program

Northfield, IL.—The College of American Pathologists Foundation (CAPF) has awarded Jennifer M. Eschbacher, MD, of the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center in Phoenix, Ariz., a $25,000 fellowship as part of CAPF 2008-09 Scholars Research Fellowship Program.

Dr. Eschbacher will receive one of four awards given from this national fellowship program. Eldad A. Hod, MD, of Columbia University in New York, N.Y.; Jacqueline E. Payton, MD, of Washington University School of Medicine in St. Louis, Mo.; and Stephen M. Rohan, MD, of Memorial Sloan-Kettering Cancer Center in New York, N.Y.; are the other award recipients. The Scholars program provides fellowships for advanced training in the science of pathology.

The CAPF Scholars program enables young medical investigators to develop independent and productive research careers by providing $25,000 in salary support for one year of translational research. Research and educational advances supported by the CAPF Scholars program benefit both the research and clinical communities by keeping talented investigators and practicing pathologists in the “pipeline” for tomorrow’s discoveries. The program promotes talent in pathology, advances productive investigation, and encourages young pathologists to pursue academic medicine.

Dr. Eschbacher’s project titled: “SOX2: A glioma-specific marker and a potential target for treatment” is designed to differentiate gliomas from nonglial tumors. She will further test the effects of inhibition of SOX2 on glioma cell behavior. A glioma specific marker will be an important diagnostic tool in the clinical setting and the potential effects of inhibition of SOX2 may further treatment progress in the glioma arena.

“I am thankful to the College for this wonderful opportunity to continue my research, as a pathologist, in the area of diagnostic neuropathology,” said Dr. Eschbacher. “I believe this research will have a significant effect upon treatment parameters.”

Dr. Eschbacher received a BS degree in biology from the University of Alaska in Anchorage and a medical degree from Wayne State University School of Medicine in Detroit, Mich. Dr. Eschbacher completed her Anatomic Pathology and Clinical Pathology residency at St. Joseph’s Hospital and Medical Center in Phoenix, Ariz. She is now a fellow in Neuropathology at the Barrow Neurological Institute.

The CAPF promotes science and education in an effort to improve the delivery of pathology services to patients and expand medical research and funding of individual research projects through sponsorship of the Scholars Research Fellowship Program.

The College of American Pathologists (CAP) is a medical society that serves more than 17,000 physician members and the laboratory community throughout the world. It is the world’s largest association composed exclusively of pathologists and is widely considered the leader in laboratory quality assurance. The CAP is an advocate for high quality and cost-effective patient care.

Contact: Maureen Jones
Phone: 800-323-4040, ext. 7439

or

Julie Monzo
Phone: 800-323-4040, ext. 7538
E-mail: publicaffairs@cap.org

 
 

 

 

   
 
 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed